Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina

Aim. To study clinical effectiveness of ivabradine (7,5 mg twice a day) as a part of combined therapy, and its effects on physical stress (PS) tolerability in patients with Functional Class (FC) II-III stable angina and absolute or relative contraindications to beta-adrenoblockers (BAB).Material and...

Full description

Bibliographic Details
Main Author: E. V. Kuleshova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2009-10-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1849
_version_ 1797882647697948672
author E. V. Kuleshova
author_facet E. V. Kuleshova
author_sort E. V. Kuleshova
collection DOAJ
description Aim. To study clinical effectiveness of ivabradine (7,5 mg twice a day) as a part of combined therapy, and its effects on physical stress (PS) tolerability in patients with Functional Class (FC) II-III stable angina and absolute or relative contraindications to beta-adrenoblockers (BAB).Material and methods. In total, 16 patients with FC II-III stable angina were examined. The examination included the assessment of angina attack incidence and need for short-acting nitrates, as well as treadmill test or 24-hour electrocardiography (ECG) monitoring.Results. Adding ivabradine to combined therapy or changing BAB to ivabradine is associated with a significant reduction in angina attach incidence, need for short-acting nitrates, heart rate at rest and at maximal PS, and total duration of myocardial ischemia, as well as with improved PS tolerability and cardiovascular system efficiency.Conclusion. In patients with absolute or relative contraindications to BAB or with poor BAB tolerability, a selective If channel inhibitor ivabradine improved clinical course of stable angina, stress test results and 24-hour ECG monitoring parameters.
first_indexed 2024-04-10T03:39:06Z
format Article
id doaj.art-1895d3e94737449a9df9bec791b8dbbc
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2024-04-10T03:39:06Z
publishDate 2009-10-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-1895d3e94737449a9df9bec791b8dbbc2023-03-13T07:23:17Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252009-10-018516211564Effectiveness of a selective If channel inhibitor ivabradine in patients with stable anginaE. V. Kuleshova0Федеральный Центр сердца, крови и эндокринологии им. В.А.Алмазова РосмедтехнологийAim. To study clinical effectiveness of ivabradine (7,5 mg twice a day) as a part of combined therapy, and its effects on physical stress (PS) tolerability in patients with Functional Class (FC) II-III stable angina and absolute or relative contraindications to beta-adrenoblockers (BAB).Material and methods. In total, 16 patients with FC II-III stable angina were examined. The examination included the assessment of angina attack incidence and need for short-acting nitrates, as well as treadmill test or 24-hour electrocardiography (ECG) monitoring.Results. Adding ivabradine to combined therapy or changing BAB to ivabradine is associated with a significant reduction in angina attach incidence, need for short-acting nitrates, heart rate at rest and at maximal PS, and total duration of myocardial ischemia, as well as with improved PS tolerability and cardiovascular system efficiency.Conclusion. In patients with absolute or relative contraindications to BAB or with poor BAB tolerability, a selective If channel inhibitor ivabradine improved clinical course of stable angina, stress test results and 24-hour ECG monitoring parameters.https://cardiovascular.elpub.ru/jour/article/view/1849стабильная стенокардияивабрадинлечение
spellingShingle E. V. Kuleshova
Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina
Кардиоваскулярная терапия и профилактика
стабильная стенокардия
ивабрадин
лечение
title Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina
title_full Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina
title_fullStr Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina
title_full_unstemmed Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina
title_short Effectiveness of a selective If channel inhibitor ivabradine in patients with stable angina
title_sort effectiveness of a selective if channel inhibitor ivabradine in patients with stable angina
topic стабильная стенокардия
ивабрадин
лечение
url https://cardiovascular.elpub.ru/jour/article/view/1849
work_keys_str_mv AT evkuleshova effectivenessofaselectiveifchannelinhibitorivabradineinpatientswithstableangina